Viewing nowNew statin A Tablets 5 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201401265 · Approved 2014.03.19 · Insurance code 647803950
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is used in cases of primary hypercholesterolemia or mixed dyslipidemia that are difficult to control with diet and exercise. Additionally, it is used as an adjunct to other therapies in patients with homozygous familial hypercholesterolemia to lower cholesterol levels in the blood. It reduces total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients aged between 10 and 17 years who exceed certain LDL cholesterol criteria. It is also utilized in the treatment of primary dysbetalipoproteinemia. It helps reduce the risks of stroke, myocardial infarction, and vascular reintervention in high-risk individuals with cardiovascular disease risk factors. This medication is effective in treating cholesterol-related diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Doses should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, those who are allergic to any of its ingredients, patients with severely impaired liver function, those with muscle diseases, patients with severely compromised kidney function, and women who are pregnant or breastfeeding should not take this medication. Furthermore, liver function tests and muscle condition should be checked before taking this medication, and patients with a history of liver disease or excessive alcohol consumption need to exercise caution. If symptoms such as muscle pain or weakness, or sudden muscle pain occur, contact a physician immediately, and if these symptoms are severe, medication should be stopped. This medication may cause increased blood sugar levels in some patients; therefore, patients at risk of diabetes should regularly check their blood sugar and hemoglobin A1c levels. Additionally, this medication may increase blood concentration when taken with certain other drugs, raising the risk of muscle damage, so consult a physician or pharmacist if other medications are being taken. Women of childbearing potential should use appropriate contraception, and this medication should not be used during pregnancy or if planning to become pregnant. Patients should also watch for unusual symptoms such as abnormal liver function, muscle issues, or skin rashes while taking this medication, and consult medical personnel immediately if such symptoms occur. In the case of an overdose, there is no specific antidote, and treatment according to symptoms, along with liver function and muscle enzyme testing, is required. Lastly, since this medication may cause side effects such as dizziness, caution is required when driving or operating machinery.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, numbness, abnormal sensations, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Yellow circular film-coated tablets
30 tablets/box [10 tablets/PTP*3], 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.